Soonpin Yei

Soonpin Yei is a seasoned professional in the biotechnology and pharmaceutical industries, holding a Ph.D. in Microbiology and Immunology from Wright State University. Currently serving as a Senior Scientist at Sorrento Therapeutics, Inc. since April 2016, Soonpin Yei has extensive experience in various roles, including Principal Scientist at Locanabio, Inc. and Sr Scientist IX at Scantibodies Laboratory, Inc. Notable expertise includes drug discovery, assay development, monoclonal antibody generation, and in vivo pharmacology. Yei has contributed to significant projects ranging from cancer therapeutics to pharmacokinetics across multiple organizations, including roles at PRESCOS LLC and Bio-Quant, Inc., as well as positions in earlier career phases with Immune Response Corporation and Genetic Therapy, Inc. Retirement occurred on April 15, 2021, to prioritize family responsibilities.